 | • レポートコード：B-MOR-08349 • 出版社/出版日：Mordor Intelligence / 2018年5月24日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、マイクロガイドカテーテルの世界市場について調べ、マイクロガイドカテーテルの世界規模、市場動向、市場環境、製品タイプ別（オーバーザワイヤー、フローダイレクト）分析、適応症別（心臓血管、神経血管、その他）分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・マイクロガイドカテーテルの世界市場インサイト ・マイクロガイドカテーテルの世界市場環境 ・マイクロガイドカテーテルの世界市場動向 ・マイクロガイドカテーテルの世界市場規模 ・マイクロガイドカテーテルの世界市場規模：製品タイプ別（オーバーザワイヤー、フローダイレクト） ・マイクロガイドカテーテルの世界市場規模：適応症別（心臓血管、神経血管、その他） ・マイクロガイドカテーテルの世界市場規模：エンドユーザー別 ・マイクロガイドカテーテルの世界市場：地域別市場規模・分析 ・マイクロガイドカテーテルの北米市場規模・予測 ・マイクロガイドカテーテルのアメリカ市場規模・予測 ・マイクロガイドカテーテルのヨーロッパ市場規模・予測 ・マイクロガイドカテーテルのアジア市場規模・予測 ・マイクロガイドカテーテルのインド市場規模・予測 ・マイクロガイドカテーテルの韓国市場規模・予測 ・関連企業情報・競争状況 |
The global micro guided catheter market is expected to register a CAGR of about 7.6%, over the forecast period, 2018-2023. The steerable catheters have demonstrated many advantages to overcome the limitations of the conventional catheters in the minimally invasive surgery.
Technological Advancement
Remote‐controlled catheter navigation systems have recently been introduced into minimally invasive vascular surgery and some of them have already been applied in clinical practice. Steerable catheters with improved maneuverability play an important role in these innovations for conventional catheterization. The steerable catheters have demonstrated many advantages to overcome the limitations of the conventional catheters in the minimally invasive surgery. Steerable catheters are able to select direction in the distal end, and superior to conventional counterparts in many aspects. Differences between magnetic and active catheters mainly lie in function, safety, configuration of operating room and cost. They have similar requirements for miniaturization and slave insertion mechanisms. Steerable catheters are rapidly evolving and still require technological refinements to extend current capabilities. This will act as driver for the market growth in the forecast period. Other factors that will affect market growth positively include increase in adoption of minimally invasive surgeries,
Significant Product Recalls
Major companies, like Medtronic and Stryker are recalling their micro guide catheter products from the market. Stryker‘s neurovascular division recalled for Boston Scientific‘s Guider guide catheter it distributes over issues with an incomplete seal that could lead to blood loss. These factors affect the image of these products and hence the perception of user and healthcare providers towards the products. These will be detrimental to the growth micro guide catheters market and will act as a restraint for the market. Other factors that will act as restraints for the market include lack of reimbursement policies in emerging markets.
North America to Maintain Dominance
North America is the most attractive market in the viral inactivation industry and is expected to be the first preference for new entrants due to the increasing end-use in the region, followed by Europe. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.
Key Developments in the Market:
• January 2017 – FDA has granted Teleflex clearance to market its TrapLiner catheter, a device designed for use in accessing the peripheral and coronary vasculature along with guide catheters. The device comes with an integrated balloon to allow a standard 0.014-inch guide wire to be trapped inside a guide catheter
Major Players: ASAHI INTECC CO., LTD, BOSTON SCIENTIFIC CORPORATION, CARDINAL HEALTH, COOK MEDICAL, INTEGER HOLDINGS CORPORATION, KONINKLIJKE PHILIPS N.V., MEDTRONIC PLC, MERIT MEDICAL SYSTEMS, INC., PENUMBRA, INC., AND TERUMO EUROPE NV, amongst others.
Reasons to Purchase the Report
• Current and future micro guide catheters market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Technological Advancement
6.1.2 Increase In Adoption of Minimally Invasive Surgeries
6.1.3 Safety And Effective Use of Product
6.1.4 Changing in Life Style
6.2 Market Restraints
6.2.1 Lack of Reimbursement Policies in Emerging Markets
6.2.2 Significant Product Recalls
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Over-the-wire
7.1.2 Flow-directed
7.2 By Indication
7.2.1 Cardiovascular
7.2.2 Neurovascular
7.2.3 Others
7.3 By End-users
7.3.1 Hospitals
7.3.2 Specialty Clinics
7.3.3 Ambulatory Surgery Centers
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 India
7.4.3.2 Australia & New Zealand
7.4.3.3 South korea
7.4.3.4 Rest of Asia-Pacific
7.4.4 Rest of World
7.4.4.1 Saudi Arabia
7.4.4.2 Brazil
7.4.4.3 Others
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Asahi Intecc Co., Ltd
9.2 Boston Scientific Corporation
9.3 Cardinal Health
9.4 Cook Medical
9.5 Integer Holdings Corporation
9.6 Koninklijke Philips N.V.
9.7 Medtronic Plc
9.8 Merit Medical Systems, Inc.
9.9 Penumbra, Inc.
9.10 Terumo Europe NV
*List Not Exhaustive
10. Future of the Market